In vitro and in vivo antimicrobial efficacy of natural plant-derived compounds against Vibrio cholerae of O1 El Tor Inaba serotype

Bioscience, Biotechnology and Biochemistry

Volumn 79, Issue 3, 2015, Pages 475-483

  Kim, Hyung Ip ^a   Kim, Ji Ae ^a   Choi, Eun Jin ^a   Harris, Jason B ^b,c   Jeong, Seong Yeop ^d   Son, Seok Jun ^e   Kim, Younghoon ^e   Shin, Ok Sarah ^a  

^a Korea University College of Medicine   (South Korea)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d Microbial Institute for Fermentation Industry (MIFI)   (South Korea)

^e Chonbuk National University   (South Korea)

Author keywords

Antibacterial effect; C. Elegans; Honokiol; Magnolol; V. Cholerae

Indexed keywords

ASSAYS; BACTERIA; FLAVONOIDS;

ANTIBACTERIAL EFFECTS; ELEGANS; HONOKIOL; MAGNOLOL; V. CHOLERAE;

PLANTS (BOTANY);

CAENORHABDITIS ELEGANS; NEGIBACTERIA; VIBRIO CHOLERAE;

ANTIINFECTIVE AGENT; ANTIINFLAMMATORY AGENT; BIOLOGICAL PRODUCT; LIPOPOLYSACCHARIDE; PLANT EXTRACT;

ANIMAL; BIOFILM; CAENORHABDITIS ELEGANS; CELL LINE RAW 264.7; CHOLERA; DRUG EFFECTS; FOOD; MACROPHAGE; MOUSE; PHYSIOLOGY; VIBRIO CHOLERAE;

ANIMALS; ANTI-BACTERIAL AGENTS; ANTI-INFLAMMATORY AGENTS; BIOFILMS; BIOLOGICAL PRODUCTS; CAENORHABDITIS ELEGANS; CHOLERA; FOOD; LIPOPOLYSACCHARIDES; MACROPHAGES; MICE; PLANT EXTRACTS; RAW 264.7 CELLS; VIBRIO CHOLERAE;

EID: 84938575489     PISSN: 09168451     EISSN: 13476947     Source Type: Journal    
DOI: 10.1080/09168451.2014.991685     Document Type: Article

References (38)

1. Harris JB, LaRocque RC, Qadri F, Ryan ET, Calderwood SB. Cholera. Lancet. 2012;379:2466-2476.
2. Faruque AS, Alam K, Malek MA, Khan MG, Ahmed S, Saha D, Khan WA, Nair GB, Salam MA, Luby SP, Sack DA. Emergence of multidrug-resistant strain of Vibrio cholerae O1 in Bangladesh and reversal of their susceptibility to tetracycline after two years. J Health Popul Nutr. 2007;25:241-243.
3. Saha D, Karim MM, Khan WA, Ahmed S, Salam MA, Bennish ML. Single-dose azithromycin for the treatment of cholera in adults. N Engl J Med. 2006;354:2452-2462.
4. Srinivas NR. Baicalin, an emerging multi-therapeutic agent: pharmacodynamics, pharmacokinetics, and considerations from drug development perspectives. Xenobiotica. 2010;40:357-367.
5. Bai X, Cerimele F, Ushio-Fukai M, Waqas M, Campbell PM, Govindarajan B, Der CJ, Battle T, Frank DA, Ye K, Murad E, Dubiel W, Soff G, Arbiser JL. Honokiol, a small molecular weight natural product, inhibits angiogenesis in vitro and tumor growth in vivo. J. Biol. Chem. 2003;278:35501-35507.
6. Battle TE, Arbiser J, Frank DA. The natural product honokiol induces caspase-dependent apoptosis in B-cell chronic lymphocytic leukemia (B-CLL) cells. Blood. 2005;106:690-697.
7. Lee J, Jung E, Park J, Jung K, Lee S, Hong S, Park J, Park E, Kim J, Park S, Park D. Anti-inflammatory effects of magnolol and honokiol are mediated through inhibition of the downstream pathway of MEKK-1 in Nf-κb activation signaling. Planta Med. 2005;71:338-343.
8. Park J, Lee J, Jung E, Park Y, Kim K, Park B, Jung K, Park E, Kim J, Park D. In vitro antibacterial and anti-inflammatory effects of honokiol and magnolol against Propionibacterium sp. Eur. J. Pharmacol. 2004;496:189-195.
9. Jacobo-Salcedo Mdel R, Gonzalez-Espindola LA, Alonso-Castro AJ, Gonzalez-Martinez Mdel R, Dominguez F, Garcia-Carranca A. Antimicrobial activity and cytotoxic effects of Magnolia dealbata and its active compounds. Nat. Prod. Commun. 2011;6:1121-1124
10. Ho KY, Tsai CC, Chen CP, Huang JS, Lin CC. Antimicrobial activity of honokiol and magnolol isolated from Magnolia officinalis. Phytother Res. 2001;15:139-141.
11. Bang KH, Kim YK, Min BS, Na MK, Rhee YH, Lee JP, Bae KH. Antifungal activity of magnolol and honokiol. Arch. Pharmacal Res. 2000;23:46-49.
12. Das T, Mukherjee S, Chaudhuri K. Effect of quercetin on Vibrio cholerae induced nuclear factor-κB activation and interleukin-8 expression in intestinal epithelial cells. Microbes Infect. 2012;14: 690-695.
13. Morinaga N, Yahiro K, Noda M. Resveratrol, a natural polyphenolic compound, inhibits cholera toxin-induced cyclic AMP accumulation in Vero cells. Toxicon. 2010;56:29-35.
14. Zhu J, Miller MB, Vance RE, Dziejman M, Bassler BL, Mekalanos JJ. Quorum-sensing regulators control virulence gene expression in Vibrio cholerae. Proc. Nat. Acad. Sci. U.S.A. 2002;99:3129-3134.
15. Kim Y, Mylonakis E. Caenorhabditis elegans immune conditioning with the probiotic bacterium Lactobacillus acidophilus strain NCFM enhances gram-positive immune responses. Infect Immun. 2012;80:2500-2508.
16. Suzuki T, Campbell J, Kim Y, Swoboda JG, Mylonakis E, Walker S, Gilmore MS. Wall teichoic acid protects Staphylococcus aureus from inhibition by Congo red and other dyes. J. Antimicrob. Chemother. 2012;67:2143-2151.
17. Lasa I, Del Pozo JL, Penades JR, Leiva J. Bacterial biofilms and infection. An Sist Sanit Navar. 2005;28:163-175.
18. Watnick PI, Paula I. Watnick - elucidating the role of biofilms. Interview by Pam Das. Lancet Infect Dis. 2002;2:190-192.
19. Bari SM, Roky MK, Mohiuddin M, Kamruzzaman M, Mekalanos JJ, Faruque SM. Quorum-sensing autoinducers resuscitate dormant Vibrio cholerae in environmental water samples. Proc. Nat. Acad. Sci. U.S.A. 2013;110:9926-9931.
20. Kamruzzaman M, Udden SM, Cameron DE, Calderwood SB, Nair GB, Mekalanos JJ, Faruque SM. Quorum-regulated biofilms enhance the development of conditionally viable, environmental Vibrio cholerae. Proc. Nat. Acad. Sci. U.S.A. 2010;107:1588-1593.
21. Zahid MS, Udden SM, Faruque AS, Calderwood SB, Mekalanos JJ, Faruque SM. Effect of phage on the infectivity of Vibrio cholerae and emergence of genetic variants. Infect Immun. 2008;76:5266-5273.
22. Faruque SM, Biswas K, Udden SM, Ahmad QS, Sack DA, Nair GB, Mekalanos JJ. Transmissibility of cholera: in vivo-formed biofilms and their relationship to infectivity and persistence in the environment. Proc. Nat. Acad. Sci. U.S.A. 2006;103:6350-6355.
23. Paulovicova E, Kovacova E, Bystricky S. Vibrio cholerae O1 Ogawa detoxified lipopolysaccharide structures as inducers of cytokines and oxidative species in macrophages. J. Med. Microbiol. 2010;59:158-164.
24. West AP, Brodsky IE, Rahner C, Woo DK, Erdjument-Bromage H, Tempst P, Walsh MC, Choi Y, Shadel GS, Ghosh S. TLR signalling augments macrophage bactericidal activity through mitochondrial ROS. Nature. 2011;472:476-480.
25. Kostyuk VA, Potapovich AI, Suhan TO, de Luca C, Korkina LG. Antioxidant and signal modulation properties of plant polyphenols in controlling vascular inflammation. Eur. J. Pharmacol. 2011;658:248-256.
26. Vaitkevicius K, Lindmark B, Ou G, Song T, Toma C, Iwanaga M, Zhu J, Andersson A, Hammarstrom ML, Tuck S, Wai SN. A Vibrio cholerae protease needed for killing of Caenorhabditis elegans has a role in protection from natural predator grazing. Proc. Nat. Acad. Sci. U.S.A. 2006;103:9280-9285.
27. Cinar HN, Kothary M, Datta AR, Tall BD, Sprando R, Bilecen K, Yildiz F, McCardell B. Vibrio cholerae hemolysin is required for lethality, developmental delay, and intestinal vacuolation in Caenorhabditis elegans. PLoS ONE. 2010;5:e11558.
28. Jefferson KK. What drives bacteria to produce a biofilm? FEMS Microbiol. Lett. 2004;236:163-173.
29. Zhu J, Mekalanos JJ. Quorum sensing-dependent biofilms enhance colonization in Vibrio cholerae. Dev. Cell. 2003;5:647-656.
30. Augustine N, Wilson PA, Kerkar S, Thomas S. Arctic Actinomycetes as potential inhibitors of Vibrio cholerae biofilm. Curr. Microbiol. 2012;64:338-342.
31. Sengupta TK, Chaudhuri K, Majumdar S, Lohia A, Chatterjee AN, Das J. Interaction of Vibrio cholerae cells with beta-lactam antibiotics: emergence of resistant cells at a high frequency. Antimicrob. Agents Chemother. 1992;36:788-795.
32. Taguri T, Tanaka T, Kouno I. Antimicrobial activity of 10 different plant polyphenols against bacteria causing food-borne disease. Biol. Pharm. Bull. 2004;27:1965-1969.
33. Kamruzzaman M, Bari SM, Faruque SM. In vitro and in vivo bactericidal activity of Vitex negundo leaf extract against diverse multidrug resistant enteric bacterial pathogens. Asia-Pac.Trop. Med. 2013;6:352-359.
34. Labrousse A, Chauvet S, Couillault C, Kurz CL, Ewbank JJ. Caenorhabditis elegans is a model host for Salmonella typhimurium. Curr. Biol. 2000;10:1543-1545.
35. Kurz CL, Ewbank JJ. Caenorhabditis elegans for the study of host-pathogen interactions. Trends Microbiol. 2000;8:142-144.
36. Tan MW, Ausubel FM. Caenorhabditis elegans: a model genetic host to study Pseudomonas aeruginosa pathogenesis. Curr. Opin. Microbiol. 2000;3:29-34.
37. Chan BC, Ip M, Lau CB, Lui SL, Jolivalt C, Ganem-Elbaz C, Litaudon M, Reiner NE, Gong H, See RH, Fung KP, Leung PC. Synergistic effects of baicalein with ciprofloxacin against NorA over-expressed methicillin-resistant Staphylococcus aureus (MRSA) and inhibition of MRSA pyruvate kinase. J. Ethnopharmacol. 2011;137:767-773.
38. Birdi T, Daswani P, Brijesh S, Tetali P, Natu A, Antia N. Newer insights into the mechanism of action of Psidium guajava L. leaves in infectious diarrhoea. BMC Complem. Altern. Med. 2010;10:33.